| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
35,922 |
31,554 |
$1.29M |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
12,343 |
11,714 |
$986K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
12,453 |
11,520 |
$627K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
10,153 |
9,478 |
$412K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
4,670 |
4,603 |
$380K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
3,322 |
3,268 |
$252K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
2,483 |
2,448 |
$221K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
20,373 |
9,722 |
$215K |
| G0315 |
Immunization counseling by a physician or other qualified health care professional for covid-19, ages under 21, 5-15 mins time (this code is used for the medicaid early and periodic screening, diagnostic, and treatment benefit (epsdt) |
5,497 |
5,346 |
$194K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
13,595 |
13,049 |
$188K |
| 99000 |
|
14,720 |
12,960 |
$143K |
| S8301 |
Infection control supplies, not otherwise specified |
34,815 |
29,255 |
$97K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
886 |
863 |
$65K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
4,922 |
3,888 |
$39K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
2,892 |
1,701 |
$36K |
| 99050 |
|
2,642 |
2,504 |
$33K |
| 90461 |
|
2,966 |
2,365 |
$18K |
| 87807 |
|
1,073 |
1,003 |
$11K |
| 0071A |
|
269 |
267 |
$11K |
| 80061 |
Lipid panel |
940 |
928 |
$11K |
| 83655 |
|
927 |
912 |
$10K |
| 0072A |
|
190 |
190 |
$8K |
| 96160 |
|
3,546 |
3,299 |
$6K |
| 85018 |
|
3,036 |
2,980 |
$6K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
428 |
211 |
$6K |
| 99429 |
|
429 |
422 |
$5K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
93 |
91 |
$5K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
466 |
460 |
$4K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
153 |
147 |
$4K |
| 82947 |
|
920 |
907 |
$3K |
| 81003 |
|
1,393 |
1,252 |
$3K |
| 99072 |
|
32,935 |
27,732 |
$2K |
| G8510 |
Screening for depression is documented as negative, a follow-up plan is not required |
177 |
176 |
$2K |
| 17110 |
|
19 |
12 |
$2K |
| 97169 |
|
132 |
132 |
$1K |
| 99381 |
|
13 |
13 |
$1K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
60 |
59 |
$826.04 |
| 0073A |
|
14 |
14 |
$601.44 |
| 0002A |
|
14 |
14 |
$578.00 |
| 0001A |
|
14 |
14 |
$566.00 |
| 69210 |
|
12 |
12 |
$466.36 |
| 90480 |
|
13 |
13 |
$360.00 |
| A7003 |
Administration set, with small volume nonfiltered pneumatic nebulizer, disposable |
189 |
181 |
$331.47 |
| 94761 |
|
1,699 |
1,616 |
$112.02 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
17 |
12 |
$95.31 |
| 86580 |
|
13 |
13 |
$85.58 |
| A4616 |
Tubing (oxygen), per foot |
254 |
245 |
$11.41 |
| 97803 |
|
12,045 |
11,719 |
$7.80 |
| 90651 |
|
1,994 |
1,968 |
$0.40 |
| 90633 |
|
494 |
485 |
$0.14 |
| 90700 |
|
684 |
681 |
$0.13 |
| 90648 |
|
1,040 |
1,030 |
$0.11 |
| 90686 |
|
3,241 |
3,184 |
$0.07 |
| 90716 |
|
663 |
653 |
$0.06 |
| 90707 |
|
659 |
650 |
$0.06 |
| 90670 |
|
954 |
942 |
$0.06 |
| G0447 |
Face-to-face behavioral counseling for obesity, 15 minutes |
9,778 |
9,543 |
$0.05 |
| G0439 |
Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit |
10,360 |
10,240 |
$0.04 |
| 90713 |
|
254 |
252 |
$0.04 |
| 90744 |
|
469 |
464 |
$0.03 |
| 90677 |
|
123 |
123 |
$0.02 |
| 90660 |
|
1,148 |
1,138 |
$0.02 |
| 90723 |
|
350 |
347 |
$0.01 |
| 90734 |
|
398 |
396 |
$0.01 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
161 |
156 |
$0.00 |
| 90680 |
|
202 |
200 |
$0.00 |
| 91307 |
|
536 |
527 |
$0.00 |
| 90381 |
|
17 |
12 |
$0.00 |
| G0136 |
Administration of a standardized, evidence-based assessment of physical activity and nutrition, 5-15 minutes, not more often than every 6 months |
539 |
470 |
$0.00 |
| 91305 |
|
16 |
16 |
$0.00 |
| 90620 |
|
61 |
61 |
$0.00 |
| G0270 |
Medical nutrition therapy; reassessment and subsequent intervention(s) following second referral in same year for change in diagnosis, medical condition or treatment regimen (including additional hours needed for renal disease), individual, face to face with the patient, each 15 minutes |
10,657 |
10,369 |
$0.00 |
| G0438 |
Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit |
211 |
205 |
$0.00 |
| 90715 |
|
149 |
148 |
$0.00 |
| 91300 |
|
65 |
62 |
$0.00 |